Search

NEWS & REPORTS

Investor Relations

Investor Relations News

, Investors

Evonik appoints new managers to its segments’ boards


Johann-Caspar Gammelin, currently Chairman of the Board of Management of Evonik Performance Materials GmbH, will take over as Chairman of the Board of Management of Evonik Nutrition and Care GmbH from Dr. Reiner Beste, effective April 1, 2019.

More
, Investors

Evonik acquires PeroxyChem for US$625 million


Evonik Industries AG has signed an agreement with One Equity Partners to acquire US-based PeroxyChem for US$625 million.

More
, Investors

Evonik strengthens its activities in Precision Livestock Farming with acquisition of Belgian Big Data software provider Porphyrio


• Evonik’s Animal Nutrition business expands activities into digital animal farming
• Expansion of analytics & software expertise for managing livestock operations

More
, Investors

Good results in third quarter


• Sales up by 7 percent to €3.8 billion
• Adjusted EBITDA rises 8 percent to €692 million
• Full-year outlook for 2018 confirmed

More
, Investors

Evonik invests in precision livestock start-up to improve poultry production


Evonik has invested in the startup OPTIfarm Ltd. through its venture capital unit and now holds a minority stake in the company, which is headquartered in Chesterfield (United Kingdom).

More
, Investors

Evonik concludes sale of its Jayhawk site


• Company continues to focus on high-margin specialty chemicals businesses
• US site transferred to Permira funds on November 1
• Proceeds in the high double-digit million range (USD)

More
more
Contact & Service

Contacts in the Investor Relations Depart-ment

more

Disclaimer

more